Genmab A/S (GMAB)

35.19 +0.36 (+1.03%) USD  |  NASDAQ  |  Sep 25, 12:47
More

Genmab Cash and Short Term Investments (Quarterly) : 1.503B for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GMAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 1.503B
March 31, 2026 1.521B
December 31, 2025 1.715B
September 30, 2025 3.411B
June 30, 2025 2.899B
March 31, 2025 3.226B
December 31, 2024 2.930B
September 30, 2024 2.593B
June 30, 2024 2.261B
March 31, 2024 4.284B
December 31, 2023 4.169B
September 30, 2023 3.908B
June 30, 2023 3.646B
March 31, 2023 3.580B
December 31, 2022 3.204B
September 30, 2022 3.134B
June 30, 2022 3.039B
March 31, 2022 2.990B
December 31, 2021 2.957B
September 30, 2021 2.921B
June 30, 2021 2.851B
March 31, 2021 2.858B
December 31, 2020 2.643B
September 30, 2020 2.752B
June 30, 2020 1.926B
Date Value
March 31, 2020 1.906B
December 31, 2019 1.648B
September 30, 2019 1.623B
June 30, 2019 1.061B
March 31, 2019 1.027B
December 31, 2018 935.38M
September 30, 2018 918.24M
June 30, 2018 951.33M
March 31, 2018 940.65M
December 31, 2017 874.58M
September 30, 2017 823.52M
June 30, 2017 799.96M
March 31, 2017 683.27M
December 31, 2016 556.34M
September 30, 2016 595.00M
June 30, 2016 561.78M
March 31, 2016 533.89M
December 31, 2015 508.49M
September 30, 2015 479.65M
June 30, 2015 441.77M
March 31, 2015 423.39M
December 31, 2014 432.34M
September 30, 2014 447.76M
June 30, 2014 474.58M
March 31, 2014 467.00M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 6.569B
Ascendis Pharma A/S 928.66M
Zealand Pharma A/S 2.211B
Bavarian Nordic A/S 360.60M
Evaxion AS 14.00M